Evidence map›Paper›PMID 39857834›Full record

ReviewChildren (Basel, Switzerland)2024

GH Therapy in Non-Growth Hormone-Deficient Children.

Chiara Guzzetti, Anastasia Ibba, Valeria Incandela, Sandro Loche

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Children (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chiara GuzzettiSSD Pediatric Endocrinology and Neonatal Screening Centre, Microcitemico Pediatric Hospital, 09121 Cagliari, Italy.ORCID 0000-0002-6927-7214
Anastasia IbbaSSD Pediatric Endocrinology and Neonatal Screening Centre, Microcitemico Pediatric Hospital, 09121 Cagliari, Italy.ORCID 0000-0002-6899-3884
Valeria IncandelaSSD Pediatric Endocrinology and Neonatal Screening Centre, Microcitemico Pediatric Hospital, 09121 Cagliari, Italy.
Sandro LocheResearch Area for Innovative Therapy in Endocrinology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0003-4558-8533

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Before 1985, growth hormone (GH) was extracted from human pituitaries, and its therapeutic use was limited to children with severe GH deficiency (GHD). The availability of an unlimited amount of recombinant GH (rhGH) allowed for investigating the efficacy of its therapeutic use in a number of conditions other than GHD. Nowadays, patients with Turner syndrome,

Indexed as

childrenchronic kidney diseasegrowth hormoneidiopathic short staturelong-acting growth hormoneNoonan syndromePrader–Willi syndromeSHOX deficiencysmall for gestational ageTurner syndrome

Identifiers

PMID39857834
PMCPMC11764098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.